课题基金 / 基金详情

Molecular Structure and Regulation of the Permeability Transition Pore

Molecular Structure and Regulation of the Permeability Transition Pore
渗透率转变孔的分子结构和调控
批准号:
7729756
负责人:
MICHAEL A FORTE
金额:
$34.15万
依托单位国家:
美国
项目类别:
财政年份:
2004
资助国家:
美国
项目状态:
已结题
起止时间:
2004-04-01 至 2011-08-31

项目摘要

项目成果

MICHAEL A FORTE的其他基金

相似基金

相关文献

中文摘要
翻译
描述(申请人提供):线粒体在细胞存活和组织发育中发挥着关键作用,因为它们在能量代谢、调节细胞内钙稳态和细胞凋亡方面发挥着重要作用。鉴于这种多因素的作用,细胞功能的这些方面必须作为一个综合系统运行。因此,线粒体的钙稳态必须受到严格的调控,并建立在一系列特定的摄取和释放系统的基础上。然而,线粒体可以很容易地经历线粒体内膜(IMM)对相对较大的溶质的通透性增加,称为通透性转换(PT),通过线粒体通透性转换孔(PTP)的调节开放。关于PTP的功能特性有大量的信息,PTP的病理性激活可以对线粒体功能产生重大影响。因此,长期以来,人们一直知道PTP在与人类病理事件相关的线粒体功能障碍中发挥关键作用,如缺血再灌注损伤和神经退行性变。然而,尽管在过去的30年里进行了详细的功能描述,但传统PTP模型中的候选孔隙成分都没有经受住关键的基因测试。从本质上讲,我们对形成和调节PTP的分子组成的了解非常贫乏。这项建议的总体目标是使用我们开发的药理、生化和遗传工具来公正地鉴定参与PTP形成的蛋白质,然后进行各种测试以确认它们在PTP活性中的作用。由于PTP已被证明在各种人类疾病中发挥关键作用,我们预计对形成或调节PTP形成的蛋白质的严格鉴定将提高我们定义针对这一重要蛋白质复合体的治疗的能力。我们的具体计划包括:1)外周苯二氮卓类受体(PBR),它仍然是传统PTP模型中唯一未经严格基因测试的生化鉴定成分。这一目标的目的是通过有条件地消除PBR的表达来应用关于PBR参与PTP的形成或调节的基因测试。2)生化数据表明,CyPD与一组有限的IMM位点有很高的亲和力,遗传分析表明它是PTP的关键调节因子。因此,这一目标的目的是在串联亲和纯化策略中使用CyPD分子来鉴定PTP的成分,然后严格测试它们的作用。3)在高等生物中,很大一部分SHCA的p66亚型定位于线粒体,在那里它与Cyt结合。C,并作为氧化还原酶,在产生活性氧物种(ROS)的过程中,将电子从细胞色素c传递到分子氧。由于ROS是PTP的有效诱导者,PTP被认为是线粒体p66作用于凋亡通路的直接下游靶点。这一目标的目的将是利用我们掌握的遗传和分子工具来确定p66依赖的通路和PTP之间的确切关系,这一联系尚未得到关键的建立。公共卫生相关性:线粒体通透性转换孔已经研究了50多年,并与心脏和脑的缺血再灌注损伤、VI型胶原缺乏引起的肌肉营养不良以及MS期间发生的轴突损伤等许多病理条件有关。由于对PTP的分子组成知之甚少,我们在这一应用中的目标是使用我们建立的药理学、生化和遗传工具来公正地鉴定参与PTP形成的蛋白质,并使用各种体外和体内测试来确认它们作为毛孔本身的核心成分或毛孔活动的调节因子的作用。由于PTP与人类各种病理条件直接相关,我们预计,对形成或调节PTP形成的蛋白质进行严格和仔细的鉴定将提高我们定义针对这些蛋白质的疗法作为对各种人类疾病的治疗的能力。
英文摘要
DESCRIPTION (provided by applicant): Mitochondria play a pivotal role in cell survival and tissue development by virtue of their role in energy metabolism, regulation of cellular Ca2+ homeostasis and apoptosis. Given this multifactorial role, these aspects of cellular function must operate as an integrated system. Consequently, mitochondrial Ca2+ homeostasis must be tightly regulated and is based in a series of specific uptake and release systems. Yet, mitochondria can easily undergo an inner mitochondrial membrane (IMM) permeability increase to relatively large solutes called the permeability transition (PT), through the regulated opening of an IMM pore, the mitochondrial permeability transition pore (PTP). A great deal of information is available about the functional properties of the PTP and pathological activation of the PTP can have dramatic consequences on mitochondrial function. As a result, the PTP has long been known to play a key role in mitochondrial dysfunction associated with human pathological events such as ischemia-reperfusion injury and neurodegeneration. However, despite detailed functional characterization over the last 30 years, none of the candidate pore components in traditional models of the PTP has withstood critical genetic tests. In essence then, we have a remarkably poor understanding of the molecular components forming and regulating the PTP. The overall goal of this proposal is to use the pharmacological, biochemical and genetic tools that we have developed for the unbiased identification of proteins involved in the formation of the PTP, followed by a variety of tests to confirm their roles in PTP activity. Since the PTP has been demonstrated to play a critical role in variety of human diseases, we anticipate that the rigorous identification of proteins forming or regulating the formation of the PTP increases our ability to define therapies targeting this important complex of proteins. Our specific plans include: 1) The peripheral benzodiazepine receptor (PBR), which remains the only biochemically identified component included in traditional models of the PTP that has not been subjected to rigorous genetic testing. The goal of this aim is to apply genetic tests of the involvement of the PBR in the formation or regulation of the PTP through conditional elimination of PBR expression. 2) Biochemical data indicate that CyPD binds with high affinity to a limited set of IMM sites and genetic analysis has demonstrated that it is a key regulator of the PTP. Consequently, the goal of this aim is to employ the CyPD molecule in tandem affinity purification strategies for the identification of components of the PTP, followed by rigorous testing of their roles. 3) In higher organisms, a significant fraction of the p66 isoform of ShcA is localized to mitochondria where it binds cyt. c and acts as an oxidoreductase, shuttling electrons from cyt c to molecular oxygen in the creation of reactive oxygen species (ROS). Since ROS are potent inducers of the PTP, the PTP has been proposed to constitute the immediate downstream target of mitochondrial p66 action in the activation of apoptotic pathways. The goal of this aim will be to use of the genetic and molecular tools at our disposal to define the exact relationship between p66-dependent pathways and the PTP, a link that has yet to be critically established. PUBLIC HEALTH RELEVANCE: The mitochondrial permeability transition pore has been studied for over 50 years and has been implicated, for example, in ischemia-reperfusion injury of the heart and brain, muscular dystrophy caused by collagen VI deficiency, and in the axonal damage occurring during MS among many other pathological conditions. Since little is known of the molecular composition of the PTP, our goals in this application are to use the pharmacological, biochemical and genetic tools we have established for the unbiased identification of proteins involved in the formation of the PTP and to use a variety of in vitro and in vivo tests to confirm their roles, either as core components of the pore itself, or regulators of pore activity. Since the PTP is of direct relevance to variety of human pathological conditions, we anticipate that the rigorous and careful identification of proteins forming or regulating the formation of the PTP will increase our ability to define therapies targeting these proteins as treatments for a wide variety of human diseases.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Molecular Dissection of the Permeability Transition Pore
Molecular Dissection of the Permeability Transition Pore
Molecular Structure and Regulation of the Permeability Transition Pore
Molecular Dissection of the Permeability Transition Pore
海外基金